CCIA
CMD

Campbell & Co Investment Adviser’s Cantel Medical Corporation CMD Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,061
Closed -$394K – 489
2017
Q2 		$394K Buy
+5,061
New +$380K 0.37% 82

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Campbell & Co Investment Adviser's CMD Position: Q3 2017 in Review

Campbell & Co Investment Adviser sold out of Cantel Medical Corporation (CMD) in Q3 2017, closing a stake of 5,061 shares — an estimated $394K sold.

Campbell & Co Investment Adviser first reported a position in CMD in Q2 2017 and held it in 1 quarter. The position peaked at $394K in Q2 2017. 231 funds tracked by Wall St. Rank hold CMD as of Q3 2017.

  • Campbell & Co Investment Adviser reported no remaining Cantel Medical Corporation position as of Q3 2017 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 5,061 Cantel Medical Corporation shares in Q3 2017, an estimated $394K.
  • Campbell & Co Investment Adviser first reported a position in Cantel Medical Corporation in Q2 2017 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's Cantel Medical Corporation position peaked at $394K in Q2 2017.
  • 231 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2017.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2017, filed 13 Nov 2017.